Skip to Content

Lung Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition

Author :
Edited by Sarah B. Goldberg, MD, MPH and Roy S. Herbst, MD, PhD
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and mol ...view more
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more. 
ISBN :
9780443183065
Publication Date :
12-05-2023
Add to Cart
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more. 

Key Features
  • Contains 15 relevant, practice-oriented topics including lung cancer screening; advances in surgical techniques for lung cancer; non-surgical therapy for early-stage lung cancer; locally advanced lung cancer; what’s new in small cell lung cancer; and more. 

  • Provides in-depth clinical reviews on lung cancer, offering actionable insights for clinical practice. 

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 


Author Information
Edited by Sarah B. Goldberg, MD, MPH, Associate Professor of Medicine (Medical Oncology), Research Director, Center for Thoracic Cancers Associate Director, Hematology/Oncology Fellowship Program, Yale Comprehensive Cancer Center and Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine